Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Descemet Stripping Endothelial Keratoplasty | 52 | 2024 | 110 | 18.180 |
Why?
|
Endothelium, Corneal | 59 | 2024 | 212 | 14.120 |
Why?
|
Descemet Membrane | 33 | 2024 | 70 | 9.030 |
Why?
|
Fuchs' Endothelial Dystrophy | 22 | 2024 | 103 | 6.800 |
Why?
|
Corneal Transplantation | 20 | 2024 | 315 | 6.790 |
Why?
|
Eye Banks | 21 | 2024 | 40 | 6.110 |
Why?
|
Tissue Donors | 39 | 2024 | 2381 | 5.470 |
Why?
|
Corneal Diseases | 24 | 2024 | 535 | 4.660 |
Why?
|
Cornea | 26 | 2024 | 1316 | 4.260 |
Why?
|
Tissue and Organ Harvesting | 15 | 2023 | 373 | 3.970 |
Why?
|
Organ Preservation | 7 | 2021 | 393 | 2.680 |
Why?
|
Corneal Endothelial Cell Loss | 10 | 2023 | 24 | 2.410 |
Why?
|
Cell Count | 25 | 2023 | 1832 | 2.260 |
Why?
|
Tissue and Organ Procurement | 8 | 2024 | 986 | 1.670 |
Why?
|
Cell Culture Techniques | 7 | 2021 | 1667 | 1.620 |
Why?
|
Cryopreservation | 5 | 2020 | 733 | 1.380 |
Why?
|
Organ Preservation Solutions | 3 | 2020 | 104 | 1.350 |
Why?
|
Tissue Preservation | 4 | 2021 | 173 | 1.320 |
Why?
|
Biological Specimen Banks | 3 | 2021 | 788 | 1.220 |
Why?
|
Endothelial Cells | 16 | 2024 | 3589 | 1.140 |
Why?
|
Learning Curve | 3 | 2024 | 232 | 1.100 |
Why?
|
Transportation | 3 | 2021 | 217 | 1.060 |
Why?
|
Corneal Stroma | 4 | 2021 | 166 | 1.040 |
Why?
|
Visual Acuity | 15 | 2024 | 2714 | 1.010 |
Why?
|
Serum Albumin | 2 | 2019 | 677 | 0.980 |
Why?
|
Organ Culture Techniques | 5 | 2021 | 796 | 0.940 |
Why?
|
Culture Media | 6 | 2021 | 898 | 0.900 |
Why?
|
Epithelium, Corneal | 5 | 2022 | 247 | 0.880 |
Why?
|
rho-Associated Kinases | 1 | 2024 | 290 | 0.810 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2024 | 221 | 0.790 |
Why?
|
Graft Survival | 7 | 2023 | 3887 | 0.720 |
Why?
|
Serum | 2 | 2019 | 206 | 0.720 |
Why?
|
Dextrans | 3 | 2018 | 574 | 0.700 |
Why?
|
Limbus Corneae | 2 | 2020 | 144 | 0.690 |
Why?
|
Keratoplasty, Penetrating | 2 | 2020 | 143 | 0.660 |
Why?
|
Dehydration | 2 | 2020 | 216 | 0.610 |
Why?
|
Anterior Chamber | 2 | 2021 | 194 | 0.610 |
Why?
|
Culture Media, Conditioned | 1 | 2019 | 521 | 0.600 |
Why?
|
Eye Burns | 1 | 2018 | 64 | 0.590 |
Why?
|
Ophthalmology | 1 | 2024 | 560 | 0.580 |
Why?
|
Trabecular Meshwork | 1 | 2018 | 101 | 0.580 |
Why?
|
Graft Rejection | 5 | 2021 | 4492 | 0.570 |
Why?
|
Hyaluronic Acid | 2 | 2019 | 484 | 0.560 |
Why?
|
Microscopy, Polarization | 1 | 2016 | 88 | 0.520 |
Why?
|
Cell Adhesion | 2 | 2019 | 3097 | 0.500 |
Why?
|
Amides | 1 | 2017 | 452 | 0.460 |
Why?
|
Retina | 3 | 2015 | 2662 | 0.460 |
Why?
|
Humans | 95 | 2024 | 768171 | 0.450 |
Why?
|
Chondroitin Sulfates | 3 | 2019 | 174 | 0.430 |
Why?
|
Cell Survival | 8 | 2024 | 5789 | 0.420 |
Why?
|
Cell Movement | 2 | 2024 | 5213 | 0.420 |
Why?
|
Cryoprotective Agents | 1 | 2014 | 128 | 0.420 |
Why?
|
Eye Evisceration | 1 | 2012 | 22 | 0.410 |
Why?
|
Extracellular Matrix | 1 | 2020 | 1738 | 0.410 |
Why?
|
Stem Cell Transplantation | 2 | 2018 | 1599 | 0.400 |
Why?
|
Choroid | 1 | 2014 | 364 | 0.390 |
Why?
|
Blindness | 1 | 2015 | 587 | 0.380 |
Why?
|
Keratoconus | 1 | 2013 | 112 | 0.370 |
Why?
|
MicroRNAs | 2 | 2023 | 3803 | 0.340 |
Why?
|
Cell Proliferation | 5 | 2024 | 10478 | 0.290 |
Why?
|
Aged | 27 | 2023 | 171502 | 0.290 |
Why?
|
Medical Errors | 1 | 2016 | 1260 | 0.290 |
Why?
|
Trypan Blue | 2 | 2024 | 20 | 0.290 |
Why?
|
Cadaver | 3 | 2023 | 1364 | 0.280 |
Why?
|
Complex Mixtures | 2 | 2018 | 29 | 0.270 |
Why?
|
Retrospective Studies | 20 | 2023 | 81760 | 0.270 |
Why?
|
Tomography, Optical Coherence | 9 | 2023 | 2957 | 0.270 |
Why?
|
Microscopy, Atomic Force | 2 | 2017 | 250 | 0.260 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2020 | 945 | 0.250 |
Why?
|
Gentamicins | 2 | 2018 | 244 | 0.250 |
Why?
|
Biomedical Research | 1 | 2021 | 3463 | 0.240 |
Why?
|
Pyridines | 1 | 2017 | 2894 | 0.240 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5432 | 0.230 |
Why?
|
Male | 31 | 2024 | 364731 | 0.220 |
Why?
|
Female | 30 | 2024 | 397187 | 0.210 |
Why?
|
Organophosphorus Compounds | 1 | 2024 | 211 | 0.210 |
Why?
|
Aniridia | 1 | 2023 | 36 | 0.210 |
Why?
|
Ubiquinone | 1 | 2024 | 183 | 0.210 |
Why?
|
Isoquinolines | 1 | 2024 | 354 | 0.210 |
Why?
|
Intraoperative Complications | 2 | 2020 | 1171 | 0.200 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2024 | 254 | 0.200 |
Why?
|
Apoptosis | 2 | 2024 | 9527 | 0.200 |
Why?
|
Ultraviolet Rays | 2 | 2024 | 1103 | 0.200 |
Why?
|
Pandemics | 2 | 2021 | 8747 | 0.190 |
Why?
|
Complement C5 | 1 | 2021 | 104 | 0.190 |
Why?
|
Conjunctivitis, Allergic | 1 | 2021 | 124 | 0.170 |
Why?
|
Melanins | 1 | 2022 | 292 | 0.170 |
Why?
|
Wound Healing | 2 | 2024 | 2815 | 0.170 |
Why?
|
Silica Gel | 1 | 2019 | 4 | 0.170 |
Why?
|
Laboratories | 1 | 2023 | 463 | 0.170 |
Why?
|
Middle Aged | 19 | 2023 | 223487 | 0.160 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2024 | 757 | 0.160 |
Why?
|
Ethidium | 1 | 2018 | 27 | 0.160 |
Why?
|
Tissue Banks | 1 | 2020 | 183 | 0.160 |
Why?
|
Intercalating Agents | 1 | 2018 | 33 | 0.160 |
Why?
|
Stem Cell Niche | 1 | 2022 | 347 | 0.160 |
Why?
|
Specimen Handling | 2 | 2021 | 707 | 0.160 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13586 | 0.150 |
Why?
|
Fluoresceins | 1 | 2018 | 235 | 0.150 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1143 | 0.150 |
Why?
|
Tensile Strength | 1 | 2019 | 335 | 0.150 |
Why?
|
Plasma Substitutes | 1 | 2016 | 57 | 0.140 |
Why?
|
Rabbits | 1 | 2023 | 4773 | 0.140 |
Why?
|
Cataract | 1 | 2023 | 837 | 0.140 |
Why?
|
Amnion | 1 | 2018 | 204 | 0.140 |
Why?
|
Living Donors | 1 | 2021 | 647 | 0.140 |
Why?
|
Antioxidants | 1 | 2024 | 1676 | 0.130 |
Why?
|
Cleft Lip | 2 | 2012 | 512 | 0.130 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11930 | 0.130 |
Why?
|
Lymphatic Vessels | 1 | 2020 | 356 | 0.130 |
Why?
|
Cleft Palate | 2 | 2012 | 597 | 0.130 |
Why?
|
Animal Testing Alternatives | 1 | 2015 | 15 | 0.130 |
Why?
|
Sodium Hydroxide | 1 | 2015 | 37 | 0.130 |
Why?
|
Epithelial Cells | 3 | 2022 | 3703 | 0.130 |
Why?
|
Connexin 43 | 1 | 2016 | 202 | 0.130 |
Why?
|
Irritants | 1 | 2015 | 43 | 0.120 |
Why?
|
Caustics | 1 | 2015 | 33 | 0.120 |
Why?
|
DNA Repair | 1 | 2024 | 2050 | 0.120 |
Why?
|
Haplorhini | 1 | 2015 | 523 | 0.120 |
Why?
|
Connexins | 1 | 2016 | 355 | 0.120 |
Why?
|
Sulfonamides | 1 | 2024 | 1982 | 0.120 |
Why?
|
Microscopy, Confocal | 1 | 2020 | 1972 | 0.120 |
Why?
|
Air | 1 | 2014 | 187 | 0.110 |
Why?
|
Cattle | 1 | 2019 | 3819 | 0.110 |
Why?
|
Stem Cells | 3 | 2022 | 3538 | 0.110 |
Why?
|
Refraction, Ocular | 1 | 2015 | 188 | 0.110 |
Why?
|
Retinal Diseases | 1 | 2020 | 710 | 0.110 |
Why?
|
Mice | 6 | 2024 | 82049 | 0.110 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20225 | 0.110 |
Why?
|
Quality Assurance, Health Care | 1 | 2024 | 2176 | 0.110 |
Why?
|
Swine | 1 | 2023 | 5997 | 0.110 |
Why?
|
Drug Combinations | 1 | 2019 | 2089 | 0.110 |
Why?
|
Oxidative Stress | 1 | 2024 | 3140 | 0.110 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2125 | 0.110 |
Why?
|
Animals | 9 | 2024 | 169285 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2012 | 2592 | 0.100 |
Why?
|
Dissection | 1 | 2014 | 299 | 0.100 |
Why?
|
Education, Medical, Graduate | 1 | 2024 | 2420 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 2 | 2012 | 2810 | 0.100 |
Why?
|
Actins | 1 | 2019 | 2064 | 0.090 |
Why?
|
Microscopy | 1 | 2016 | 909 | 0.090 |
Why?
|
Principal Component Analysis | 1 | 2014 | 948 | 0.090 |
Why?
|
Quality Control | 1 | 2014 | 836 | 0.090 |
Why?
|
Tissue Engineering | 2 | 2021 | 1893 | 0.090 |
Why?
|
Mitochondria | 1 | 2024 | 3683 | 0.090 |
Why?
|
Retinal Degeneration | 1 | 2015 | 414 | 0.090 |
Why?
|
Cells, Cultured | 3 | 2024 | 19025 | 0.090 |
Why?
|
Preoperative Period | 1 | 2013 | 565 | 0.090 |
Why?
|
Ectodermal Dysplasia | 1 | 2011 | 107 | 0.090 |
Why?
|
Fluorescent Dyes | 1 | 2018 | 1931 | 0.090 |
Why?
|
Cell Line | 2 | 2022 | 15602 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6512 | 0.080 |
Why?
|
Vision, Ocular | 1 | 2013 | 458 | 0.080 |
Why?
|
Analysis of Variance | 1 | 2018 | 6229 | 0.080 |
Why?
|
Treatment Failure | 1 | 2016 | 2661 | 0.080 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4834 | 0.080 |
Why?
|
Autopsy | 1 | 2013 | 1011 | 0.080 |
Why?
|
Neovascularization, Physiologic | 1 | 2016 | 1370 | 0.080 |
Why?
|
Aged, 80 and over | 4 | 2023 | 59626 | 0.080 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22380 | 0.080 |
Why?
|
Mosaicism | 1 | 2012 | 480 | 0.080 |
Why?
|
Clinical Competence | 1 | 2024 | 4858 | 0.080 |
Why?
|
Germ Cells | 1 | 2012 | 644 | 0.080 |
Why?
|
Postoperative Period | 1 | 2013 | 1826 | 0.080 |
Why?
|
Models, Biological | 1 | 2024 | 9497 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2024 | 5704 | 0.070 |
Why?
|
Ophthalmic Solutions | 2 | 2021 | 312 | 0.070 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18349 | 0.070 |
Why?
|
Comorbidity | 1 | 2021 | 10590 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2018 | 15833 | 0.060 |
Why?
|
Reoperation | 1 | 2016 | 4329 | 0.060 |
Why?
|
Feasibility Studies | 1 | 2016 | 5315 | 0.060 |
Why?
|
G2 Phase | 1 | 2024 | 135 | 0.060 |
Why?
|
DNA Damage | 2 | 2024 | 2469 | 0.060 |
Why?
|
Glucose | 1 | 2016 | 4352 | 0.060 |
Why?
|
Prospective Studies | 3 | 2018 | 54924 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2024 | 65379 | 0.060 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2024 | 297 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Smoke | 1 | 2024 | 242 | 0.050 |
Why?
|
Cause of Death | 1 | 2013 | 3721 | 0.050 |
Why?
|
Transcription Factors | 2 | 2012 | 12171 | 0.050 |
Why?
|
Adult | 5 | 2023 | 223646 | 0.050 |
Why?
|
Donor Selection | 1 | 2024 | 240 | 0.050 |
Why?
|
Horses | 1 | 2022 | 295 | 0.050 |
Why?
|
Myofibroblasts | 1 | 2022 | 230 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2014 | 12466 | 0.040 |
Why?
|
Leukotriene B4 | 1 | 2021 | 281 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39354 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 9016 | 0.040 |
Why?
|
Italy | 1 | 2021 | 856 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2024 | 1105 | 0.040 |
Why?
|
Cyclosporine | 1 | 2021 | 777 | 0.040 |
Why?
|
Fundus Oculi | 1 | 2020 | 560 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 872 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 24318 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1737 | 0.040 |
Why?
|
Eye | 1 | 2022 | 712 | 0.040 |
Why?
|
Regenerative Medicine | 1 | 2021 | 313 | 0.040 |
Why?
|
Equipment Design | 2 | 2015 | 3522 | 0.030 |
Why?
|
Estrogens | 1 | 2023 | 1536 | 0.030 |
Why?
|
Inflammation | 1 | 2016 | 10873 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2024 | 2152 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2017 | 211 | 0.030 |
Why?
|
Phacoemulsification | 1 | 2018 | 151 | 0.030 |
Why?
|
Lens Implantation, Intraocular | 1 | 2018 | 192 | 0.030 |
Why?
|
Silver Nitrate | 1 | 2015 | 12 | 0.030 |
Why?
|
Cell Separation | 1 | 2021 | 1728 | 0.030 |
Why?
|
Vision Disorders | 1 | 2023 | 1092 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1667 | 0.030 |
Why?
|
Corneal Opacity | 1 | 2015 | 52 | 0.030 |
Why?
|
Retinal Neurons | 1 | 2015 | 67 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1337 | 0.030 |
Why?
|
Ciliary Body | 1 | 2015 | 168 | 0.030 |
Why?
|
Fluorescein Angiography | 1 | 2020 | 1086 | 0.030 |
Why?
|
Forecasting | 1 | 2023 | 2945 | 0.030 |
Why?
|
Proteoglycans | 1 | 2017 | 809 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2016 | 1890 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 2015 | 921 | 0.020 |
Why?
|
Cell Death | 1 | 2017 | 1680 | 0.020 |
Why?
|
Surface Properties | 1 | 2015 | 1166 | 0.020 |
Why?
|
Peroxidase | 1 | 2015 | 610 | 0.020 |
Why?
|
Ascorbic Acid | 1 | 2015 | 658 | 0.020 |
Why?
|
Tight Junctions | 1 | 2014 | 324 | 0.020 |
Why?
|
Time Factors | 1 | 2013 | 40220 | 0.020 |
Why?
|
Oligopeptides | 1 | 2016 | 1194 | 0.020 |
Why?
|
Limit of Detection | 1 | 2011 | 277 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 41753 | 0.020 |
Why?
|
Neuroglia | 1 | 2015 | 960 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2024 | 14488 | 0.020 |
Why?
|
Collagen | 1 | 2017 | 2645 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8741 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2666 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2011 | 1989 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3912 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2012 | 2748 | 0.020 |
Why?
|
Reference Standards | 1 | 2011 | 1014 | 0.020 |
Why?
|
Syndrome | 1 | 2012 | 3273 | 0.020 |
Why?
|
Prenatal Diagnosis | 1 | 2012 | 1275 | 0.020 |
Why?
|
Pedigree | 1 | 2012 | 4539 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4585 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2022 | 11677 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4120 | 0.010 |
Why?
|
Base Sequence | 1 | 2011 | 12422 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13422 | 0.010 |
Why?
|
Alleles | 1 | 2011 | 6894 | 0.010 |
Why?
|
Rats | 1 | 2016 | 23782 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22290 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17623 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7601 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 60066 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 89169 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74944 | 0.010 |
Why?
|
Concepts
(254)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_